TENAX THERAPEUTICS, INC. Proceeds from Notes Payable
TENAX THERAPEUTICS, INC. (TENX) reported Proceeds from Notes Payable of $0 for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2023-11-13
- TENAX THERAPEUTICS, INC. proceeds from notes payable for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- TENAX THERAPEUTICS, INC. proceeds from notes payable for the quarter ending 2022-12-31 was $259.76K.
- TENAX THERAPEUTICS, INC. proceeds from notes payable for the quarter ending 2022-09-30 was $0.00.
- TENAX THERAPEUTICS, INC. proceeds from notes payable for the quarter ending 2022-06-30 was $0.00.
- TENAX THERAPEUTICS, INC. proceeds from notes payable for fiscal 2022 was $624.30K.
- TENAX THERAPEUTICS, INC. proceeds from notes payable for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- TENAX THERAPEUTICS, INC. proceeds from notes payable for fiscal 2020 was $244.66K.
- TENAX THERAPEUTICS, INC. proceeds from notes payable for fiscal 2019 was $0.00.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month | Proceeds from Notes Payable 530 month | Proceeds from Notes Payable 533 month | Proceeds from Notes Payable 536 month | Proceeds from Notes Payable 539 month | Proceeds from Notes Payable 542 month | Proceeds from Notes Payable 545 month | Proceeds from Notes Payable 554 month | Proceeds from Notes Payable 557 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 | |||||||||||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 | $259.76K derived: sum of 2 quarters · filed 2023-05-15 | $259.76K derived: sum of 3 quarters · filed 2023-11-13 | $259.76K derived: sum of 4 quarters · filed 2023-11-13 | ||||||||
| 2022-12-31 | $259.76K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $259.76K derived: sum of 2 quarters · filed 2023-11-13 | $259.76K derived: sum of 3 quarters · filed 2023-11-13 | $624.30K 10-K · filed 2023-03-31 | ||||||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $364.55K 10-Q · filed 2023-11-13 | $364.55K derived: sum of 4 quarters · filed 2023-11-13 | ||||||||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $364.55K 10-Q · filed 2023-08-14 | $364.55K derived: sum of 3 quarters · filed 2023-08-14 | $364.55K derived: sum of 4 quarters · filed 2023-08-14 | ||||||||
| 2022-03-31 | $364.55K 10-Q · filed 2023-05-15 | $364.55K derived: sum of 2 quarters · filed 2023-05-15 | $364.55K derived: sum of 3 quarters · filed 2023-05-15 | |||||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $0.00 derived: sum of 2 quarters · filed 2023-03-31 | $0.00 10-K · filed 2023-03-31 | |||||||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | ||||||||||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-11 | |||||||||||
| 2020-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-16 | $0.00 derived: sum of 2 quarters · filed 2021-04-16 | $244.66K 10-K/A · filed 2021-04-16 | |||||||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $244.66K 10-Q · filed 2020-11-16 | ||||||||||
| 2020-06-30 | $244.66K 10-Q · filed 2020-08-14 | |||||||||||
| 2019-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-16 | $0.00 derived: sum of 2 quarters · filed 2021-04-16 | $0.00 10-K/A · filed 2021-04-16 | |||||||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 10-Q · filed 2020-11-16 | ||||||||||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-14 | |||||||||||
| 2014-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17 | $0.00 10-Q · filed 2014-03-17 | $977.69K 10-Q · filed 2014-03-17 | |||||||||
| 2013-10-31 | $0.00 10-Q · filed 2013-12-17 | $977.69K 10-Q · filed 2013-12-17 | ||||||||||
| 2013-07-31 | $977.69K 10-Q · filed 2013-09-17 | |||||||||||
| 2013-04-30 | $977.69K 10-K · filed 2013-06-26 | |||||||||||
| 2013-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17 | $0.00 10-Q · filed 2014-03-17 | $977.69K 10-Q · filed 2013-03-18 | |||||||||
| 2012-10-31 | $0.00 10-Q · filed 2013-12-17 | $977.69K 10-Q · filed 2012-12-14 | ||||||||||
| 2012-07-31 | $977.69K 10-Q · filed 2012-09-19 | |||||||||||
| 2012-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-25 | $0.00 derived: sum of 2 quarters · filed 2012-07-25 | $0.00 derived: sum of 3 quarters · filed 2012-07-25 | $0.00 10-K · filed 2012-07-25 | $977.69K 10-K · filed 2012-07-25 | |||||||
| 2012-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-15 | $0.00 derived: sum of 2 quarters · filed 2012-03-15 | $0.00 10-Q · filed 2012-03-15 | $0.00 derived: sum of 4 quarters · filed 2012-07-25 | $977.69K 10-Q · filed 2012-03-15 | |||||||
| 2011-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-15 | $0.00 10-Q · filed 2011-12-15 | $0.00 derived: sum of 3 quarters · filed 2012-07-25 | $0.00 derived: sum of 4 quarters · filed 2012-07-25 | $977.69K 10-Q · filed 2011-12-15 | |||||||
| 2011-07-31 | $0.00 10-Q · filed 2011-09-19 | $0.00 derived: sum of 2 quarters · filed 2012-07-25 | $0.00 derived: sum of 3 quarters · filed 2012-07-25 | $0.00 derived: sum of 4 quarters · filed 2012-07-25 | $977.69K 10-Q · filed 2011-09-19 | |||||||
| 2011-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-25 | $0.00 derived: sum of 2 quarters · filed 2012-07-25 | $0.00 derived: sum of 3 quarters · filed 2012-07-25 | $0.00 10-K · filed 2012-07-25 | ||||||||
| 2011-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-03-15 | $0.00 derived: sum of 2 quarters · filed 2012-03-15 | $0.00 10-Q · filed 2012-03-15 | |||||||||
| 2010-10-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2011-12-15 | $0.00 10-Q · filed 2011-12-15 | ||||||||||
| 2010-07-31 | $0.00 10-Q · filed 2011-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |